Apax Partners

Capio hält nach Ablauf der Hauptangebotsfrist 98.13% der Stimmrechte von Unilabs

Götheburg, Schweden, 9. November 2007 – Capio teilt heute mit, dass das Unternehmen und die in gemeinsamer Absprache handelnden Gesellschaften und Personen nach Ablauf der  Hauptangebotsfrist am 5. November 2007 98.13% der Stimmen aller ausgegebenen Unilabs-Aktien halten.

Seit Beginn des Angebotes am 9. Oktober bis zum Abschluss der Hauptangebotsfrist am 5. November, 16.00 MEZ wurden insgesamt 3’091’344 Unilabs-Inhaberaktien, 5 Unilabs-Namenaktien and insgesamt 3’642’844 Optionen auf Unilabs-Inhaberaktien angedient.

Bereits am 5. Oktober hatte Capio den Abschluss des Kaufs des Pakets von Unilabs-Namen- und Inhaberaktien und Optionen von den Mehrheitsaktionären bekanntgegeben.

Die obligatorische Nachfrist dauert vom 9. bis zum 22. November 2007, 16.00 MEZ. Nach Abschluss des Angebots beabsichtigt Capio, Unilabs von SWX Swiss Exchange zu dekotieren.

Das Übernahmeangebot beträgt CHF 57.50 pro Inhaberaktie, CHF 28.75 pro Namenaktie und CHF 1.75 pro Inhaberaktien-Option netto in bar. Der Preis für die Unilabs-Inhaberaktien entspricht einer Prämie von 30.30 % gegenüber dem während 60 Tagen vor der Voranmeldung am 7. August 2007 an SWX Swiss Exchange erzielten volumengewichteten Durchschnittskurs.

Für weitere Informationen: http://www.ulbcap.info/,  http://www.capio.com/; www.capiodiagnostik.se;
Oder kontaktieren Sie Paul Hökfelt, Capio
Mobiltelefon: +41 76 507 3333
Eemail: phokfelt@capio.com

Disclaimer
This document does not constitute an offer to sell or to purchase securities, nor a solicitation of an offer to sell or to purchase securities, whether in the context of the intended public tender offer in Switzerland by Capio Laboratories AB, Sweden (formerly Goldcup J 2653 AB, Sweden) (hereinafter "Capio") on the shares or option rights of Unilabs SA (hereinafter "Unilabs") or in any jurisdiction where such offer, solicitation, sale or the acceptance of such offer may be unlawful. It does also not constitute a recommendation to sell or buy shares in Capio or Unilabs. The public tender offer to the public shareholders of Unilabs and to the holders of option rights (the "Offer"), will not be made in any jurisdiction where it is contrary to applicable law or where applicable law requires Capio to modify the Offer, to submit an additional application to any authorities or other institutions, or to undertake any additional action in connection with this Offer. It is not intended to extend the Offer to any such jurisdictions. Documents related to the Offer may neither be distributed in such jurisdictions nor be sent into such jurisdictions. Persons in such jurisdictions may not use such documents to solicit purchases of securities of Unilabs.

U.S. Restrictions
The Offer will not be made, directly or indirectly, in or into the United States of America (the U.S.) or by use of the U.S. mails, or by any means or instrumentality (including, without limitation, post, facsimile transmission, telex, telephone or electronic transmission by way of the internet or otherwise) of U.S. interstate or foreign commerce or of any facility of a U.S. national securities exchange and the Offer cannot be accepted by any such use, means or instrumentality or from within the U.S. Capio will not be soliciting the tender of securities of Unilabs by any holder of such securities in the U.S. Unilabs securities will not be accepted from holders of such securities in the U.S. Any purported acceptance of the Offer that Capio or its agents believe has been made in or from the U.S. will be invalidated. Capio reserves the absolute right to reject any and all acceptances determined by them not to be in the proper form or the acceptance of which may be unlawful. Copies of the preannouncement and offer prospectus or any related offering documents must not be mailed or otherwise distributed or sent in or into the U.S. and may not be used for the purpose of soliciting the purchase of any securities of Unilabs from anyone in any jurisdiction, including the U.S., in which such solicitation is not authorized or from any person to whom it is unlawful to make such solicitation. Any person receiving the pre-announcement and|or offer prospectus (including custodians, nominees and trustees) must observe these restrictions.